✦ LIBER ✦

9328 The Italian experience on the feasibility and safety of ipilimumab therapy in pretreated metastatic melanoma patients

✍ Scribed by Altomonte, M.; Queirolo, P.; Testori, A.; Ascierto, P.; Danielli, R.; Giacomo, A.M. Di; Sileni, V. Chiarion; Del Vecchio, M.; Ridolfi, R.; Maio, M.

Book ID: 122013020
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 49 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71972-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9327 Ipilimumab in the common daily prac

9327 Ipilimumab in the common daily practice: feasibility, safety, efficacy and long-term follow-up in heavily pretreated metastatic melanoma patients

✍ Giacomo, A.M. Di; Danielli, R.; Calabrò, L.; Bertocci, E.; Nannicini, C.; Miracc 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Efficacy and safety of ipilimumab in eld

Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme

✍ Chiarion Sileni, Vanna; Pigozzo, Jacopo; Ascierto, Paolo; Grimaldi, Antonio; Mai 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 265 KB

P523 Efficacy and safety of adalimumab (

P523 Efficacy and safety of adalimumab (ADA) therapy in pediatric Crohn's disease (CD) patients who failed infliximab (IFX): a multicenter experience of the Italian Society of Pediatric Gastroenterology Hepatology and Nutrition (SIGENP)

✍ Alvisi, P.; Barabino, A.; Cucchiara, S.; Miele, E.; Romano, C.; Ravelli, A.; Kna 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 66 KB

Multicentre surveillance study on feasib

Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real-life combo study

✍ Candoni, A.; Caira, M.; Cesaro, S.; Busca, A.; Giacchino, M.; Fanci, R.; Delia, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB

A single-institution experience from the

A single-institution experience from the Lapatinib Expanded Access Program – effect of lapatinib and capecitabine combination therapy on CNS metastases in patients with ErbB2+ metastatic breast cancer

✍ B. Kaufman; R. Weitzen; A. Goldfarb; N. Ephrat; I. Kuchuk; T. Golan; I. Wolf; R. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB